Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
To determine the comparability of the safety and efficacy of Imiquimod Cream, 3.75% and
Zyclara (imiquimod) Cream, 3.75% (the reference listed drug) in subjects with actinic
keratosis (AK) of the face or balding scalp. It will also be determined whether the efficacy
of each of the two active treatments is superior to that of the Vehicle cream.